Ovarian Cancer: 5-ALA Imaging Study

We are testing a dye called 5-ALA to see if it helps surgeons find ovarian cancer tumors that regular methods might miss. This study aims to improve tumor detection during surgery.

≤3 months ≤5 visits Efficacy phase (II)No Placebo Partially Remote Standard Medicines OralGynecology and ObstetricsOncologyOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Gliolan

Gliolan is a medicine used during brain tumor surgery to make tumor tissue glow so surgeons can see and remove it more easily.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Aminolevulinic Acid Hydrochloride

Aminolevulinic acid hydrochloride is a substance that makes abnormal cells glow under special light to help detect or treat certain skin lesions and tumors.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitaetsklinikum Bonn AöR

Clinic for Gynecology and Gynecological Oncology

Bonn, Germany

Sponsor: Rheinische Friedrich-Wilhelms-Universitaet Bonn

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.